Our memories of past events are typically not isolated, but they are linked to other related memories. This ability to ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...

Fermeate uses optogenetics—precise control of gene expression with light—to turbocharge productivity in bioreactors, with minimal capex.

Prolific Machines technology gives developers precise, real-time control over when and how much protein a cell produces.

Researchers in South Korea say they have made a major advance by turning on genes with an electromagnetic signal, but critics ...

California-based startup Fermeate has raised $2 million in seed funding to scale its optogenetics platform, which uses light ...

Optogenetics is the science of using light to control the behavior of cells. It is one of the most rapidly evolving fields of applied research. Optogenetic techniques enable the control of ...

Though largely operating in the background until recently, Prolific Machines’ optogenetic approach to biomanufacturing is set ...

Researchers at Leipzig University have gained important insights into learning mechanisms in the brain of the fruit fly ...